Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
iGeneTRAiN. Igenetrain- an overview. 2015; 1. Available at: http://igenetrain.org/igenetrain-an-overview/. Accessed August 1, 2018.
- Looking into the crystal ball: kidney transplantation in 2025.Nat Clin Pract Nephrol. 2009; 5: 117
- The role of the CD28 receptor during T cell responses to antigen.Annu Rev Immunol. 1993; 11: 191-212
- New perspectives of CD28-B7-mediated T cell costimulation.Immunity. 1995; 2: 555-559
- T-cell costimulatory pathways in allograft rejection and tolerance.Immunol Rev. 2003; 196: 85-108
- Association of IL-6 gene polymorphism with the outcome of allogeneic haematopoietic stem cell transplantation in Czech patients.Int J Immunogenet. 2008; 35: 401-403
- Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplants.Blood. 2007; 110: 4623-4624
- IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.Transplantation. 2009; 87: 704-710
- The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.Immunity. 2004; 20: 529-538
- Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.Am J Transplant. 2005; 5: 31-39
- Why hasn't eliminating acute rejection improved graft survival?.Annu Rev Med. 2007; 58: 369-385
- HLA-DQ mismatching and kidney transplant outcomes.Clin J Am Soc Nephrol. 2018; 13: 763-771
- Negative T-cell costimulatory pathways: their role in regulating alloimmune responses.Curr Opin Organ Transplant. 2008; 13: 373-378
- Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.J Immunol. 1996; 157: 4258-4267
- The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation.Am J Transplant. 2008; 8: 2434-2444
- CD28 costimulation: from mechanism to therapy.Immunity. 2016; 44: 973-988
- New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus.Genes Immun. 2000; 1: 428-434
- The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation.Am J Transplant. 2003; 3: 424-431
- Association between co-stimulatory molecule gene polymorphism and acute rejection of allograft.Transpl Immunol. 2014; 31: 81-86
- Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients.Immunol Invest. 2014; 43: 391-404
- Polymorphisms of the Costimulatory Genes CTLA-4, CD28, PD-1, and ICOS and outcome of kidney transplants in Iranian patients.Exp Clin Transplant. 2017; 15: 295-305
- The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.J Clin Invest. 2003; 112: 234-243
- Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.Nat Immunol. 2001; 2: 591-596
- Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4.Mol Immunol. 2007; 44: 1644-1651
- Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.Clin Chim Acta. 2009; 403: 229-233
- Roles of OX40 in the pathogenesis and the control of diseases.Int J Hematol. 2006; 83: 17-22
- OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells.J Immunol. 2008; 181: 5990-6001
- OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses.Eur J Immunol. 2003; 33: 2372-2381
- Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.Blood. 2008; 112: 2847-2857
- Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.Blood. 2017; 130: 1585-1596
- Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction.Nat Genet. 2002; 32: 650-654
- A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes.Immunogenetics. 2003; 55: 149-156
- Differential binding of nuclear factors to the intron 1 sequences containing the transcriptional pause site correlates with c-myb expression.Proc Natl Acad Sci U S A. 1989; 86: 7326-7330
- F-SNP: computationally predicted functional SNPs for disease association studies.Nucleic Acids Res. 2008; 36: D820-D824
- Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices.Cell. 1994; 79: 639-648
- Annotation of functional variation in personal genomes using RegulomeDB.Genome Res. 2012; 22: 1790-1797
- HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease.Nucleic Acids Res. 2016; 44: D877-D881
- The influence of genetic variations in the CD86 gene on the outcome after allogeneic hematopoietic stem cell transplantation.J Immunol Res. 2018; 2018: 3826989
- Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients.Transpl Immunol. 2005; 15: 69-74
- CD86 +1057G>A polymorphism and susceptibility to acute kidney allograft rejection.Iran J Kidney Dis. 2011; 5: 187-193
- Coinhibitory pathways in the B7-CD28 ligand-receptor family.Immunity. 2016; 44: 955-972
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.Nature. 2003; 423: 506-511
- CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.Blood. 2007; 110: 461-467
- CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.Ann Hematol. 2010; 89: 613-618
- CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia.Bone Marrow Transplant. 2012; 47: 411-415
- Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription.Hum Immunol. 2013; 74: 1219-1224
- Lentiviral gp34/OX40L gene transfer into dendritic cells facilitates alloreactive CD4+ T-cell response in vitro.Int J Hematol. 2004; 79: 377-383
- Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo.J Exp Med. 2003; 197: 875-883
- Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations.J Clin Immunol. 2004; 24: 237-248
- A Bayesian method for the induction of probabilistic networks from data.Machine Learn. 1992; 9: 309-347
- Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.Circulation. 2008; 117: 660-669
- Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism.J Immunol. 2003; 171: 1272-1277
- PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.Ann Hematol. 2018; 97: 2217-2224
- TGF-beta: the master regulator of fibrosis.Nat Rev Nephrol. 2016; 12: 325-338
- A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.Cancer Res. 2003; 63: 2610-2615
- Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation.J Heart Lung Transplant. 2000; 19: 551-556
- A novel polymorphism of the gene encoding furin, a TGF-beta1 activator, and the influence on cardiac allograft vasculopathy formation.Transpl Immunol. 2004; 13: 185-190
- TGF-beta1 gene polymorphisms in patients with end-stage heart failure.J Heart Lung Transplant. 2001; 20: 979-984
- No association between transforming growth factor beta gene polymorphism and acute allograft rejection after cardiac transplantation.Transpl Immunol. 2002; 10: 43-47
- Association between TGFB1 genetic polymorphisms and chronic allograft dysfunction: a systematic review and meta-analysis.Oncotarget. 2017; 8: 62463-62469
- Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome.Transpl Immunol. 2008; 18: 344-348
- Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children.Kidney Int. 2003; 64: 314-320
- Transforming growth factor-beta1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation.Bone Marrow Transplant. 2017; 52: 739-744
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies.Nat Rev Rheumatol. 2016; 12: 49-62
- Cytokine gene polymorphisms predict acute graft rejection following renal transplantation.Kidney Int. 1999; 56: 281-288
- Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation.Transplantation. 2004; 78: 1422-1428
- Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation.Clin Transplant. 2007; 21: 615-621
- The polymorphism -308G/A of tumor necrosis factor-alpha gene modulates the effect of immunosuppressive treatment in first kidney transplant subjects who suffer an acute rejection.J Immunol Res. 2016; 2016: 2197595
- Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.Transpl Infect Dis. 2014; 16: 724-732
- Association of TNF-alpha, TGF-beta1, IL-10, IL-6, and IFN-gamma gene polymorphism with acute rejection and infection in lung transplant recipients.Clin Transplant. 2014; 28: 1016-1024
- Association between cytokines and their receptor antagonist gene polymorphisms and clinical risk factors and acute rejection following renal transplantation.Med Sci Monit. 2016; 22: 4736-4741
- Association of IL1 beta gene polymorphism and allograft functions in renal transplant recipients :a case control study from Kashmir Valley.BMC Nephrol. 2017; 18: 111
- History of interleukin-4.Cytokine. 2015; 75: 3-7
- Donor interleukin-4 promoter gene polymorphism influences allograft rejection after heart transplantation.J Heart Lung Transplant. 2002; 21: 340-346
- IL-6 in inflammation, immunity, and disease.Cold Spring Harb Perspect Biol. 2014; 6: a016295
- Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy?.J Heart Lung Transplant. 2005; 24: 559-565
- Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation.Transplantation. 2002; 74: 1297-1302
- Pathologic patterns of interleukin 10 expression--a review.Biochem Med (Zagreb). 2015; 25: 36-48
- Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation.N Engl J Med. 2003; 349: 2201-2210
- IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.Hum Immunol. 2005; 66: 700-710
- Interleukin-10 gene polymorphism in bone marrow transplant recipients.Exp Clin Transplant. 2008; 6: 74-79
- IL-10 gene polymorphisms in transplantation.Madame Curie Bioscience Database Landes Bioscience, Austin (Tx)2000
- Cytokine gene polymorphism might affect the outcome of clinical rejection in cardiac transplantation.J Appl Res. 2004; 4: 68-80
- A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.J Heart Transplant. 1990; 9: 587-593
- Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients.Transpl Immunol. 2003; 11: 107-119
- The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing.Nat Rev Immunol. 2014; 14: 585-600
- A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.PLoS One. 2011; 6: e26229
- A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.Science. 2006; 314: 1461-1463
- Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.Nat Genet. 2007; 39: 596-604
- Ustekinumab as induction and maintenance therapy for Crohn's disease.N Engl J Med. 2016; 375: 1946-1960
- Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.Bone Marrow Transplant. 2008; 41: 821-826
- Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients.Transplantation. 2006; 82: 1774-1780
- IL-6 SNP diversity among four ethnic groups as revealed by bead-based liquid array profiling.Int J Immunogenet. 2011; 38: 17-20
- Long- and short-term outcomes in renal allografts with deceased donors: a large recipient and donor genome-wide association study.Am J Transplant. 2018; 18: 1370-1379
- Improved allograft survival of strong immune responder-high risk recipients with adjuvant antithymocyte globulin therapy.Transplantation. 1980; 30: 450-454
- Problems of reporting genetic associations with complex outcomes.Lancet. 2003; 361: 865-872
- Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.Blood. 2016; 128: 2450-2456
- Design and implementation of the international genetics and translational research in transplantation network.Transplantation. 2015; 99: 2401-2412
- Systems biology in kidney transplantation: the application of multi-omics to a complex model.Am J Transplant. 2017; 17: 11-21
Article info
Publication history
Published online: December 24, 2018
Footnotes
Disclosure Statement: The authors have nothing to disclose.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
